Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Algernon Health Inc (AGN.CN)

Algernon Health Inc (AGN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,893
  • Shares Outstanding, K 47,332
  • Annual Sales, $ 0 K
  • Annual Income, $ -1,717 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.59
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.29
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.07
  • Most Recent Earnings $-0.02 on 01/29/26
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING:

    SIC-2834 Pharmaceutical Preparations

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0400 unch
on 03/06/26
0.0500 -20.00%
on 02/13/26
-0.0100 (-20.00%)
since 02/06/26
3-Month
0.0400 unch
on 03/06/26
0.0850 -52.94%
on 12/29/25
-0.0400 (-50.00%)
since 12/05/25
52-Week
0.0400 unch
on 03/06/26
0.1000 -60.00%
on 06/16/25
-0.0500 (-55.56%)
since 03/06/25

Most Recent Stories

More News
Algernon Announces Additional Increase to Private Placement Financing to $858,000 and Final Closing of the Financing

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR  FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or...

AGN.CN : 0.0400 (unch)
AGNPF : 0.0299 (+0.34%)
Algernon Announces Increase to Private Placement Financing to $750,000 and Close of Third Tranche

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR  FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or...

AGN.CN : 0.0400 (unch)
AGNPF : 0.0299 (+0.34%)
Algernon Closes Second Tranche of Private Placement Financing

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR  FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or...

AGN.CN : 0.0400 (unch)
AGNPF : 0.0299 (+0.34%)
Algernon Health and American Molecular Imaging Announce Strategic Business and USD $500K Investment Agreement

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or...

AGN.CN : 0.0400 (unch)
AGNPF : 0.0299 (+0.34%)
Algernon Closes First Tranche of its Recently Announced Private Placement Financing

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR  FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or...

AGN.CN : 0.0400 (unch)
AGNPF : 0.0299 (+0.34%)
Algernon Health Announces Private Placement

VANCOUVER, British Columbia, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company, is...

AGN.CN : 0.0400 (unch)
AGNPF : 0.0299 (+0.34%)
Algernon Pharmaceuticals Completes Name Change to Algernon Health

VANCOUVER, British Columbia, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company...

AGN.CN : 0.0400 (unch)
AGNPF : 0.0299 (+0.34%)
Algernon Announces CAD $4 Million Non-Dilutive Financing to Open Four Brain-Specific PET Scan Clinics in the U.S. for Early Stage Alzheimer’s Detection

VANCOUVER, British Columbia, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare...

AGN.CN : 0.0400 (unch)
AGNPF : 0.0299 (+0.34%)
Algernon Announces Preferred Share Class Approved at Annual and Special Meeting

VANCOUVER, British Columbia, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare...

AGN.CN : 0.0400 (unch)
AGNPF : 0.0299 (+0.34%)
Algernon Pharmaceuticals Announces Name Change to Algernon Health

VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare...

AGN.CN : 0.0400 (unch)
AGNPF : 0.0299 (+0.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is below 20%. The market is in extreme oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Algernon Health Inc is a clinical-stage pharmaceutical development company focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), and stroke, including a program utilizing N,N-Dimethyltryptamine (DMT)....

See More

Key Turning Points

3rd Resistance Point 0.0400
2nd Resistance Point 0.0400
1st Resistance Point 0.0400
Last Price 0.0400
1st Support Level 0.0400
2nd Support Level 0.0400
3rd Support Level 0.0400

See More

52-Week High 0.1000
Fibonacci 61.8% 0.0771
Fibonacci 50% 0.0700
Fibonacci 38.2% 0.0629
Last Price 0.0400
52-Week Low 0.0400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar